These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3747602)

  • 41. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality.
    Doi TS; Marino MW; Takahashi T; Yoshida T; Sakakura T; Old LJ; Obata Y
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2994-9. PubMed ID: 10077625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased tumor necrosis factor-alpha (TNF-alpha) gene expression in parainfluenza type 1 (Sendai) virus-induced bronchiolar fibrosis.
    Uhl EW; Moldawer LL; Busse WW; Jack TJ; Castleman WL
    Am J Pathol; 1998 Feb; 152(2):513-22. PubMed ID: 9466578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor.
    Thorne TE; Voelkel-Johnson C; Casey WM; Parks LW; Laster SM
    J Virol; 1996 Dec; 70(12):8502-7. PubMed ID: 8970973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target.
    Nishioka WK; Welsh RM
    J Exp Med; 1994 Feb; 179(2):769-74. PubMed ID: 8294885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model.
    Tufariello J; Cho S; Horwitz MS
    J Virol; 1994 Jan; 68(1):453-62. PubMed ID: 8254756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro.
    Van Campen H
    Arch Virol; 1994; 136(3-4):439-46. PubMed ID: 8031247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor.
    Lidbury BA; Ramshaw IA; Rolph MS; Cowden WB
    Arch Virol; 1995; 140(4):703-19. PubMed ID: 7794113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor.
    Shemer-Avni Y; Wallach D; Sarov I
    Infect Immun; 1988 Sep; 56(9):2503-6. PubMed ID: 3410548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.
    Titus RG; Sherry B; Cerami A
    J Exp Med; 1989 Dec; 170(6):2097-104. PubMed ID: 2584936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumour necrosis factor: a cytokine with multiple biological activities.
    Semenzato G
    Br J Cancer; 1990 Mar; 61(3):354-61. PubMed ID: 2183871
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation.
    Ames RS; Holskin B; Mitcho M; Shalloway D; Chen MJ
    J Virol; 1990 Sep; 64(9):4115-22. PubMed ID: 2143540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of TNF as antiviral, antibacterial and antiparasitic agent.
    Rook GA; Taverne J; Playfair JH
    Biotherapy; 1991; 3(2):167-75. PubMed ID: 2054257
    [No Abstract]   [Full Text] [Related]  

  • 53. Tumor necrosis factor alpha selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation.
    Wong GH; McHugh T; Weber R; Goeddel DV
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4372-6. PubMed ID: 2034677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo.
    Sambhi SK; Kohonen-Corish MR; Ramshaw IA
    Proc Natl Acad Sci U S A; 1991 May; 88(9):4025-9. PubMed ID: 2023951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor.
    Filley EA; Rook GA
    Infect Immun; 1991 Aug; 59(8):2567-72. PubMed ID: 1906841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
    Denis M
    Clin Exp Immunol; 1991 Mar; 83(3):466-71. PubMed ID: 1900745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication.
    Kobayashi N; Hamamoto Y; Yamamoto N; Ishii A; Yonehara M; Yonehara S
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9620-4. PubMed ID: 1702216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human tumor necrosis factor-alpha kills herpesvirus-infected but not normal cells.
    Koff WC; Fann AV
    Lymphokine Res; 1986; 5(3):215-21. PubMed ID: 3747602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.
    Drescher KM; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2302-12. PubMed ID: 8843914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
    Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.